3 - ((3R, 4R) -4-Methyl-3- [methyl- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) -amino] -piperidinyl) -3-oxopropionitrile as a protein kinase inhibitor
- 专利权人:
- Pfizer Products Inc.
- 发明人:
- 申请号：
- LTPA2017025
- 公开号：
- LTC1666481I2
- 申请日:
- 2017.08.08
- 申请国别(地区):
- LT
- 年份:
- 2018
- 代理人:
- 摘要：
- The compound 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile or a pharmaceutically acceptable salt thereof； compositions containing the compound； and uses of the compound in the manufacture of medicaments.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- 3 - ((3R, 4R) -4-methyl-3- [methyl- (7H-pyrrolo [2,3-d] pyrimidin-4-yl) amino] -piperidinyl) -3-oxo-propionitrile as protein kinase inhibitor
- R R metil metil H pirolo d pirimidin yl amino piperidinil oksopropionitril kot inhibitor protein kinaze
- 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile and the pharmaceutical composition and their use
- 3-((3R,4R)-4-Méthyl-3-[méthyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidinyl)-3-oxo-propionitrile comme inhibiteur de la kinase protéinique
- Tofacitinib, optionally in the form of a pharmaceutically acceptable salt, in particular tofacitinib citrate
